Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We turned a profit!

PDS may at times enter into license agreements whereby contingent revenues are recognized as one or more contractual milestones are met

Has this language always been present in 10 Qs or is this new??

Share
New Message
Please login to post a reply